FDA Clearance Tracker · P010032-S092
GENESIS AND EON FAMILY SPINAL CORD STIMULATION (SCS) SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 9, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jul 9, 2015
Approved
Time to decision
202 days
Received Dec 19, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010032-S092
- Device name
- GENESIS AND EON FAMILY SPINAL CORD STIMULATION (SCS) SYSTEM
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- Dec 19, 2014
- Decided
- Jul 9, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010032
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ST. JUDE MEDICAL INVISIBLE TRIAL SYSTEM COMPRISING OF THE FOLLOWING DEVICES:1) ST. JUDE MEDICAL EXTERNAL PULSE GENERATOR (EPG), 16 CHANNEL: MODEL 3599; 2) ST. JUDE MEDICAL CLINICIAN PROGRAMMER APP (CP): MODEL 3870;3) ST. JUDE MEDICAL PATIENT CONTROLLER APP (PC): MODEL 3871; AND 4) ASSOCIATED ACCESSORIES (LEAD MODELS 3046, 3066, AND 3086 AND MULTI-LEAD TRIAL CABLE (MLTC) 3013).THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ST. JUDE MEDICAL INVISIBLE TRIAL SYSTEM AND IS INDICATED AS AN AID IN THE MANAGEMENT OF CHRONIC, INTRACTABLE PAIN OF THE TRUNK AND/OR LIMBS, INCLUDING UNILATERAL OR BILATERAL PAIN ASSOCIATED WITH ANY OF THE FOLLOWING: FAILED BACK SURGERY SYNDROME AND INTRACTABLE LOW BACK AND LEG PAIN. THE ST. JUDE MEDICAL INVISIBLE NEUROMODULATION TRIAL SYSTEM IS INTENDED TO BE USED EXTERNALLY WITH ST. JUDE MEDICAL APPROVED TRIAL LEADS AND EXTENSIONS TO DELIVER TRIAL STIMULATION FOR A MAXIMUM OF 30 DAYS.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.